LATEST
Cencora agreed to acquire American Oncology NetworknewAPEX / KorainewSmith & Wesson Brands agreed to acquire Long Range IntermediatenewMaximus Federal Services agreed to acquire Agile DefenseMount Logan Management agreed to acquire Alternative Fund AdvisorsDime Commercial Bancshares / ES BancsharesSalesforce agreed to acquire BrazeJV Investors / Oro Mobility HoldingsMorgan Stanley Capital Partners acquired The Rapid GroupCBRE Group agreed to acquire Onnec GroupBevPoint Capital agreed to acquire ESGMarwynn Holdings acquired Zhituo Software
Open App
Agreement signedAgreed 19 Nov 2022

Merck Sharp & Dohme LLC /
Imago BioSciences, Inc.

Merck Sharp & Dohme LLC agrees to buy Imago BioSciences, Inc.

Terms
Not stated
Stage
Agreement signed
Buy side: Merck Sharp & Dohme LLC
Buy sideMerck Sharp & Dohme LLC
Target: Imago BioSciences, Inc.
TargetImago BioSciences, Inc.
Source · 19 Nov 2022
See the source
Buy side: Merck Sharp & Dohme LLC
Buy sideMerck Sharp & Dohme LLC
Target: Imago BioSciences, Inc.
TargetImago BioSciences, Inc.
01 / BuyerMerck Sharp & Dohme LLC
02 / TargetImago BioSciences, Inc.
01

What happened

Merck Sharp & Dohme LLC agreed to acquire Imago BioSciences, Inc. for $36.00 per Share, according to a filing dated Jan. 11, 2023.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

Merck Sharp & Dohme LLC agrees to buy Imago BioSciences, Inc.

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

  2. Announced

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.